| Balloon-expandable valve group (number/percent) | Self-expandable valve group (number/percent) | P-value |
Age, mean (SD) | 81.2 ± 8 | 79.8 ± 7 | P = 0.556 |
Bodyweight | 68.8 ± 2.1 | 70.6 ± 2.6 | P = 0.453 |
Height | 166.8 ± 9.7 | 163.6 ± 8.8 | P = 0.974 |
Systolic blood pressure mmHg | 125.2 ± 12.8 mmhg | 122.2 ± 19.4 | P = 0.213 |
Diastolic blood pressure mmHg | 67.5 ± 18 mmhg | 74.5 ± 14 | P = 0.603 |
Women | 7 (25%) | 8 (25%) | P = 0.571 |
EuroSCORE II, median (IQR) | 7.6 ± 3 | 5.2 ± 3 | P = 0.747 |
Society of Thoracic Surgeons score, mean (SD) | 5.1 ± 2.2 | 5.4 ± 2.6 | P = 0.507 |
NYHA Class |
|
| P = 0.306
|
Ι | 2 | 1 |
|
ΙΙ | 5 | 8 |
|
ΙΙΙ | 16 | 18 |
|
ΙV | 9 | 1 |
|
Diabetes mellitus | 12 | 4 | P = 0.057 |
Coronary artery disease | 11 (45%) | 8 (47%) | P = 0.737 |
HLP | 5 (8%) | 6 (15%) | P = 0.399 |
Myocardial infarction | 0 | 2 (11%) | P = 0.001 |
CABG | 10 (41%) | 8 (17%) | P = 0.001 |
Cerebral vascular disease | 1 | 0 | P = 0.121 |
Peripheral vascular disease | 4 | 0 |
|
Pulmonary disease | 5 (28%) | 2 (11%) | P = 0.372 |
Creatinine level, mean (SD), | 1.11 ± 0.4 | 1.17 ± 0.5 | P = 0.026 |
Severe chronic renal failure | 5 | 1 | P = 0.776 |
Atrial fibrillation | 10 (35%) | 10 (32%) | P = 0.695 |